"Diabetes Mellitus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Descriptor ID |
D003920
|
| MeSH Number(s) |
C18.452.394.750 C19.246
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus".
This graph shows the total number of publications written about "Diabetes Mellitus" by people in this website by year, and whether "Diabetes Mellitus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 6 | 1 | 7 |
| 2003 | 6 | 2 | 8 |
| 2004 | 6 | 0 | 6 |
| 2005 | 6 | 4 | 10 |
| 2006 | 10 | 3 | 13 |
| 2007 | 10 | 5 | 15 |
| 2008 | 11 | 4 | 15 |
| 2009 | 17 | 5 | 22 |
| 2010 | 21 | 5 | 26 |
| 2011 | 12 | 4 | 16 |
| 2012 | 13 | 4 | 17 |
| 2013 | 20 | 3 | 23 |
| 2014 | 13 | 6 | 19 |
| 2015 | 15 | 8 | 23 |
| 2016 | 11 | 5 | 16 |
| 2017 | 13 | 2 | 15 |
| 2018 | 9 | 1 | 10 |
| 2019 | 9 | 2 | 11 |
| 2020 | 10 | 3 | 13 |
| 2021 | 4 | 0 | 4 |
| 2022 | 5 | 0 | 5 |
| 2023 | 6 | 0 | 6 |
| 2024 | 2 | 2 | 4 |
| 2025 | 4 | 2 | 6 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus" by people in Profiles.
-
Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. Lancet HIV. 2026 May; 13(5):e297-e305.
-
Multi-site analysis of COVID-19 and new-onset diabetes reveals need for improved sensitivity of EHR-based COVID-19 phenotypes-a DiCAYA Network analysis. J Am Med Inform Assoc. 2026 Mar 01; 33(3):710-718.
-
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the Pathways Heart Study. JNCI Cancer Spectr. 2026 Jan 09; 10(1).
-
YMCA Delivery of the National Diabetes Prevention Program: National Trends and Case Study Insights. J Public Health Manag Pract. 2026 Mar-Apr 01; 32(2):170-174.
-
An Augmented Likelihood Approach Incorporating Error-Prone Auxiliary Data Into a Survival Analysis. Stat Med. 2025 Dec; 44(28-30):e70321.
-
Sociodemographic characteristics of patients throughout the recruitment process into a randomized, controlled behavioral trial. Trials. 2025 Nov 18; 26(1):519.
-
Opportunities and obstacles associated with the Medicare Diabetes Prevention Program. Am J Manag Care. 2025 Oct; 31(10):578-582.
-
A Hybrid Chart Review of Premature Coronary Artery Disease: An Opportunity to Improve Diagnostic Excellence and Management. Perm J. 2025 Sep 15; 29(3):49-55.
-
Engagement in the National Diabetes Prevention Program Among Hispanic Men. JAMA Netw Open. 2025 06 02; 8(6):e2515046.
-
The Effect of City-Level Sugar-Sweetened Beverage Taxes on Longitudinal HbA1c and Incident Diabetes in Adults With Prediabetes. Diabetes Care. 2024 Jul 01; 47(7):1220-1226.